These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34134097)

  • 1. Inhalable liposomes for treating lung diseases: clinical development and challenges.
    Ponkshe P; Feng S; Tan C
    Biomed Mater; 2021 Jul; 16(5):. PubMed ID: 34134097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications.
    Rudokas M; Najlah M; Alhnan MA; Elhissi A
    Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):60-72. PubMed ID: 26938856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomes for controlled delivery of drugs to the lung.
    Taylor KM; Newton JM
    Thorax; 1992 Apr; 47(4):257-9. PubMed ID: 1585287
    [No Abstract]   [Full Text] [Related]  

  • 4. Nebulizer-compatible liquid formulations for aerosol pulmonary delivery of hydrophobic drugs: glucocorticoids and cyclosporine.
    Klyashchitsky BA; Owen AJ
    J Drug Target; 1999; 7(2):79-99. PubMed ID: 10617295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases.
    Anderson CF; Grimmett ME; Domalewski CJ; Cui H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1586. PubMed ID: 31602823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Products-Based Inhaled Formulations for Treating Pulmonary Diseases.
    Yong J; Shu H; Zhang X; Yang K; Luo G; Yu L; Li J; Huang H
    Int J Nanomedicine; 2024; 19():1723-1748. PubMed ID: 38414528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Updates in Inhalable Drug Delivery System against Various Pulmonary Diseases: Challenges and Future Perspectives.
    Chaudhary KR; Singh K; Singh C
    Curr Drug Deliv; 2024; 21(10):1320-1345. PubMed ID: 37870055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections.
    Meers P; Neville M; Malinin V; Scotto AW; Sardaryan G; Kurumunda R; Mackinson C; James G; Fisher S; Perkins WR
    J Antimicrob Chemother; 2008 Apr; 61(4):859-68. PubMed ID: 18305202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery.
    Willis L; Hayes D; Mansour HM
    Lung; 2012 Jun; 190(3):251-62. PubMed ID: 22274758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection.
    Omri A; Suntres ZE; Shek PN
    Biochem Pharmacol; 2002 Nov; 64(9):1407-13. PubMed ID: 12392822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled Heparin: Therapeutic Efficacy and Recent Formulations.
    Yildiz-Pekoz A; Ozsoy Y
    J Aerosol Med Pulm Drug Deliv; 2017 Jun; 30(3):143-156. PubMed ID: 28418758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary delivery of anti-inflammatory agents.
    Ali ME; McConville JT; Lamprecht A
    Expert Opin Drug Deliv; 2015 Jun; 12(6):929-45. PubMed ID: 25534260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in liposomal dry powder formulations: preparation and evaluation.
    Misra A; Jinturkar K; Patel D; Lalani J; Chougule M
    Expert Opin Drug Deliv; 2009 Jan; 6(1):71-89. PubMed ID: 19236209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivering drugs to the lungs: The history of repurposing in the treatment of respiratory diseases.
    Newman SP
    Adv Drug Deliv Rev; 2018 Aug; 133():5-18. PubMed ID: 29653129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome-mediated drug targeting in topical and regional therapies.
    Margalit R
    Crit Rev Ther Drug Carrier Syst; 1995; 12(2-3):233-61. PubMed ID: 9501970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes for Inhalation.
    Ong HX; Traini D; Young PM
    J Aerosol Med Pulm Drug Deliv; 2024 Apr; 37(2):100-110. PubMed ID: 38640446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates.
    Abdelaziz HM; Gaber M; Abd-Elwakil MM; Mabrouk MT; Elgohary MM; Kamel NM; Kabary DM; Freag MS; Samaha MW; Mortada SM; Elkhodairy KA; Fang JY; Elzoghby AO
    J Control Release; 2018 Jan; 269():374-392. PubMed ID: 29180168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary delivery of insulin by liposomal carriers.
    Huang YY; Wang CH
    J Control Release; 2006 Jun; 113(1):9-14. PubMed ID: 16730838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic uses of antioxidant liposomes.
    Stone WL; Smith M
    Mol Biotechnol; 2004 Jul; 27(3):217-30. PubMed ID: 15247495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives.
    Iyer R; Hsia CC; Nguyen KT
    Curr Pharm Des; 2015; 21(36):5233-44. PubMed ID: 26412358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.